August 04, 2026

An Overlooked Cause of Pediatric Anaphylaxis

Inhaling cumin during meal preparation triggered the first reported case of pediatric cumin-induced anaphylaxis, raising awareness of spice allergy.

MDSpire News

July 22, 2026

FDA Expands Pediatric Allergy Nasal Spray Use

A phase 3 randomized, double-blind, placebo-controlled trial in pediatric patients demonstrated improved nasal symptoms compared with placebo.

MDSpire News

July 17, 2026

FDA Grants Traditional Approval to Iptacopan in Primary IgAN

Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.

MDSpire News

July 13, 2026

Does Pediatric Readiness Reduce ED Imaging?

Hospitals with stronger pediatric emergency capability used less imaging overall, but differences by insurance status and race and ethnicity remained.

MDSpire News

July 09, 2026

Top 10 CDC Updates Physicians Should Know

Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.

MDSpire News

June 29, 2026

FDA Approves Pediatric Risankizumab

Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.

MDSpire News

June 29, 2026

Measles-Related Vitamin A Searches Rise

Google Trends data showed increased US search interest in vitamin A and cod liver oil during the 2025 measles outbreak, but normalized search data cannot determine actual product use, dosing behavior, or harms.

MDSpire News

June 25, 2026

Can Tezepelumab Reduce Steroid Dependence?

Phase 3 SUNRISE trial evaluates whether patients with severe asthma can taper maintenance oral corticosteroids while maintaining asthma control.

MDSpire News

June 24, 2026

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.

MDSpire News

June 18, 2026

FDA Expands CAPVAXIVE Pediatric Use

Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.

MDSpire News